Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Intensive Crit Care Nurs ; 22(1): 59-62, 2006 Feb.
Article in English | MEDLINE | ID: mdl-16006127

ABSTRACT

Caspofungin is a member of a new class of antifungals called Echinocandins and is the first to have marketing authorisation in the United Kingdom. This article reviews the clinical efficacy, side effect profile, dosing and administration schedule of caspofungin. The article also discusses the warnings and precautions associated with the use of this drug. Caspofungin is an effective treatment option in the management of fungal infections.


Subject(s)
Antifungal Agents/therapeutic use , Mycoses/drug therapy , Peptides, Cyclic/therapeutic use , Antifungal Agents/pharmacology , Antifungal Agents/supply & distribution , Caspofungin , Drug Administration Schedule , Drug Approval , Drug Interactions , Drug Monitoring , Echinocandins , Humans , Lipopeptides , Mycoses/microbiology , Patient Selection , Peptides, Cyclic/pharmacology , Peptides, Cyclic/supply & distribution , Treatment Outcome , United Kingdom
SELECTION OF CITATIONS
SEARCH DETAIL
...